• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

含重组干扰素α-2a的可生物降解微球的研究

Study on biodegradable microspheres containing recombinant interferon-alpha-2a.

作者信息

Zhou Shaobing, Deng Xianmo, He Shuiying, Li Xiaohong, Jia Wenxiang, Wei Dapeng, Zhang Zairong, Ma Jihui

机构信息

Chengdu Institute of Organic Chemistry, Chinese Academy of Sciences, P. R. China.

出版信息

J Pharm Pharmacol. 2002 Sep;54(9):1287-92. doi: 10.1211/002235702320402143.

DOI:10.1211/002235702320402143
PMID:12356284
Abstract

In this work, a new microsphere delivery system comprising calcium alginate microcores surrounded by a biodegradable poly-DL-lactide-poly(ethylene glycol) (PELA) coat was designed to improve the loading efficiency and stability of peptide drugs. Recombinant interferon (IFN)-alpha-2a, used as a model peptide drug, was efficiently entrapped within the alginate microcores using a high-speed stirrer and then microencapsulated into PELA copolymer using a water-in-oil-in-water solvent extraction method. Microspheres were characterized in terms of morphology, size and distribution, encapsulation efficiency, IFN biological activity retention and in-vitro peptide release. The IFN potency test showed that IFN entrapped in the core-coated microspheres could retain its biological activity during the encapsulation and release procedure. The release profiles were determined by the measurement of peptide presenting in the release medium at various intervals. The IFN potency, calculated by the Wish cells/vesicular stomatitis virus system, was used to determine IFN biological activity. The results showed that the core-coated microspheres could stabilize IFN in the PELA matrix. We compared the new deliverysystem with conventional microsphere delivery systems based on biodegradable poly-DL-lactide and poly-DL-lactide-poly(ethylene glycol). The core-coated microspheres had the highest amount of entrapment, encapsulation efficiency and biological activity retention. The extent of burst release (14%) from the core-coated microspheres in the initial protein release was much lower than the 31% burst release from the conventional microspheres. In conclusion, this work presents a new approach for water-soluble macromolecular drugs delivery (e.g. protein, peptide drugs, vaccines).

摘要

在本研究中,设计了一种新型微球递送系统,该系统由海藻酸钙微核和可生物降解的聚-DL-丙交酯-聚(乙二醇)(PELA)包衣组成,旨在提高肽类药物的负载效率和稳定性。以重组干扰素(IFN)-α-2a作为模型肽类药物,使用高速搅拌器将其有效地包封在海藻酸盐微核内,然后采用水包油包水溶剂萃取法将其微囊化到PELA共聚物中。对微球进行了形态、大小和分布、包封效率、IFN生物活性保留以及体外肽释放等方面的表征。IFN效价测试表明,包封在核-壳微球中的IFN在包封和释放过程中能够保留其生物活性。通过在不同时间间隔测量释放介质中存在的肽来确定释放曲线。采用Wish细胞/水泡性口炎病毒系统计算的IFN效价用于确定IFN生物活性。结果表明,核-壳微球能够使IFN在PELA基质中稳定存在。我们将这种新型递送系统与基于可生物降解聚-DL-丙交酯和聚-DL-丙交酯-聚(乙二醇)的传统微球递送系统进行了比较。核-壳微球具有最高的包封量、包封效率和生物活性保留率。核-壳微球在初始蛋白质释放时的突释程度(14%)远低于传统微球的31%突释率。总之,本研究为水溶性大分子药物(如蛋白质、肽类药物、疫苗)的递送提供了一种新方法。

相似文献

1
Study on biodegradable microspheres containing recombinant interferon-alpha-2a.含重组干扰素α-2a的可生物降解微球的研究
J Pharm Pharmacol. 2002 Sep;54(9):1287-92. doi: 10.1211/002235702320402143.
2
Investigation on a novel core-coated microspheres protein delivery system.
J Control Release. 2001 Jul 10;75(1-2):27-36. doi: 10.1016/s0168-3659(01)00379-0.
3
Microencapsulation of recombinant adenovirus within poly-DL-lactide-poly(ethylene glycol) microspheres for enhanced gene transfection efficiency and inhibitory effects on hepatocellular carcinoma cells in vitro.聚-DL-丙交酯-聚乙二醇微球对重组腺病毒的微囊化用于增强基因转染效率及体外对肝癌细胞的抑制作用
Mol Med Rep. 2015 Aug;12(2):2336-42. doi: 10.3892/mmr.2015.3578. Epub 2015 Apr 1.
4
Preparation and characterization of biodegradable microspheres containing hepatitis B surface antigen.含乙肝表面抗原的可生物降解微球的制备与表征
Macromol Biosci. 2004 Jan 21;4(1):47-52. doi: 10.1002/mabi.200300044.
5
Investigation on process parameters involved in preparation of poly-DL-lactide-poly(ethylene glycol) microspheres containing Leptospira Interrogans antigens.含问号钩端螺旋体抗原的聚-DL-丙交酯-聚(乙二醇)微球制备过程参数的研究
Int J Pharm. 1999 Feb 15;178(2):245-55. doi: 10.1016/s0378-5173(98)00379-2.
6
Microencapsulation of protein drugs for drug delivery: strategy, preparation, and applications.蛋白质药物的微囊化给药:策略、制备及应用。
J Control Release. 2014 Nov 10;193:324-40. doi: 10.1016/j.jconrel.2014.09.003. Epub 2014 Sep 10.
7
In vitro protein release and degradation of poly-dl-lactide-poly(ethylene glycol) microspheres with entrapped human serum albumin: quantitative evaluation of the factors involved in protein release phases.载有人血清白蛋白的聚-dl-丙交酯-聚(乙二醇)微球的体外蛋白质释放与降解:对蛋白质释放阶段相关因素的定量评估
Pharm Res. 2001 Jan;18(1):117-24. doi: 10.1023/a:1011043230573.
8
Biodegradable micro- and nanoparticles as long-term delivery vehicles for interferon-alpha.可生物降解的微米和纳米颗粒作为α干扰素的长效递送载体。
Eur J Pharm Sci. 2003 Mar;18(3-4):221-9. doi: 10.1016/s0928-0987(03)00019-8.
9
Body distribution of poly-DL-lactide-poly(ethylene glycol) microspheres with entrapped leptospira interrogans antigens following intravenous and oral administration to guinea-pigs.
J Pharm Pharmacol. 2000 Jul;52(7):763-70. doi: 10.1211/0022357001774615.
10
Optimization of preparative conditions for poly-DL-lactide- polyethylene glycol microspheres with entrapped Vibrio cholera antigens.包载霍乱弧菌抗原的聚-DL-丙交酯-聚乙二醇微球制备条件的优化
J Control Release. 1999 Mar 29;58(2):123-31. doi: 10.1016/s0168-3659(98)00147-3.

引用本文的文献

1
Forms and Methods for Interferon's Encapsulation.干扰素的包封形式与方法
Pharmaceutics. 2021 Sep 22;13(10):1533. doi: 10.3390/pharmaceutics13101533.
2
Long-term delivery of protein therapeutics.蛋白质治疗药物的长期递送。
Expert Opin Drug Deliv. 2015 Mar;12(3):415-40. doi: 10.1517/17425247.2015.961420. Epub 2014 Sep 24.
3
Agile delivery of protein therapeutics to CNS.蛋白质治疗药物向中枢神经系统的快速递送。
J Control Release. 2014 Sep 28;190:637-63. doi: 10.1016/j.jconrel.2014.06.017. Epub 2014 Jun 21.
4
CCR9 interactions support ovarian cancer cell survival and resistance to cisplatin-induced apoptosis in a PI3K-dependent and FAK-independent fashion.CCR9 相互作用以依赖于 PI3K 且不依赖于 FAK 的方式支持卵巢癌细胞的存活和对顺铂诱导的细胞凋亡的抵抗。
J Ovarian Res. 2010 Jun 17;3:15. doi: 10.1186/1757-2215-3-15.
5
Past, present, and future technologies for oral delivery of therapeutic proteins.用于治疗性蛋白质口服递送的过去、现在和未来技术。
J Pharm Sci. 2008 Jul;97(7):2497-523. doi: 10.1002/jps.21183.